Publications (400) Publications in which a researcher has participated

filter_list

2025

  1. Belimumab patient profile in Spain: evolution during the last decade and future directions

    Expert Opinion on Biological Therapy, Vol. 25, Núm. 4, pp. 425-435

  2. Characteristics and clinical outcomes of patients with systemic lupus erythematosus initiating anifrolumab in a real-world setting in Spain (AZAHAR study): An observational study protocol

    Lupus Science and Medicine, Vol. 12, Núm. 1

  3. Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La

    Lupus, Vol. 34, Núm. 6, pp. 571-578

  4. Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La

    Lupus

  5. DNA methylome biomarkers of rheumatoid arthritis-associated interstitial lung disease reflecting lung fibrosis pathways, an exploratory case–control study

    Scientific Reports, Vol. 15, Núm. 1

  6. Doctor-patient communication in Systemic Lupus Erythematosus: Insights from the LupusVoice study

    SSM - Qualitative Research in Health, Vol. 7

  7. Lupus Nephritis: 10 questions to think about

    Nefrologia, Vol. 45, Núm. 2, pp. 101-105

  8. Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients

    Rheumatology, Vol. 64, Núm. 1, pp. 276-282

2024

  1. Biodegradable polydioxanone stents: histologic and structural effects in an experimental model of tracheal stenosis

    European Journal of Cardio-thoracic Surgery , Vol. 65, Núm. 4

  2. Can the dose of belimumab be reduced in patients with systemic lupus erythematosus?

    Rheumatology

  3. Correction to: An online survey of the Spanish Lupus Patient Association (FELUPUS): patient perceptions and experiences (Clinical Rheumatology, (2023), 42, 5, (1259-1265), 10.1007/s10067-023-06500-3)

    Clinical Rheumatology

  4. Correction to: Patient-reported outcome measures for systemic lupus erythematosus: an expert Delphi consensus to guide implementation in routine care (BMC Rheumatology, (2024), 8, 1, (31), 10.1186/s41927-024-00401-x)

    BMC Rheumatology

  5. Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis

    Lupus Science & Medicine, Vol. 11, Núm. 2, pp. e001064

  6. Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus: data from the Spanish society of rheumathology Lupus Register (RELESSER)

    Rheumatology International, Vol. 44, Núm. 11, pp. 2445-2455

  7. Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement?

    Rheumatology (Oxford, England), Vol. 63, Núm. 1, pp. 72-78

  8. Genetic Variants in RANK and OPG Could Influence Disease Severity and Bone Remodeling in Patients with Early Arthritis

    Life, Vol. 14, Núm. 9

  9. Genetic variants regulating the immune response improve the prediction of COVID-19 severity provided by clinical variables

    Scientific Reports, Vol. 14, Núm. 1

  10. Impact of Heat and Pressure Processing Treatments on the Digestibility of Peanut, Hazelnut, Pistachio and Cashew Allergens

    Foods, Vol. 13, Núm. 22

  11. Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study

    Lupus, Vol. 33, Núm. 7, pp. 663-674

  12. Lupus Nephritis: 10 questions to think about

    Nefrologia